Mohawk Inds SEC Filings

Mohawk Industries (MHK): Ownership update. JPMorgan Chase & Co. filed a Schedule 13G/A (Amendment No. 1) reporting beneficial ownership of 2,427,971 shares of Mohawk common stock, representing 3.9% of the class, with the event dated 09/30/2025.

JPMorgan reports sole voting power over 2,218,347 shares and sole dispositive power over 2,419,537 shares, with shared voting power over 5 shares and shared dispositive power over 8,433 shares. The filing certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Mohawk Industries (MHK) received a Form 144 notice for a proposed sale of 200 common shares. The filing lists an aggregate market value of $23,459.00, with TD Securities (USA) LLC as broker and an approximate sale date of 10/29/2025 on the NYSE.

The seller’s shares were originally acquired on 02/29/2012 via a company disbursement labeled “free receive.” The filing also notes recent activity over the past three months by the same account, including transactions such as 2,500 shares on 07/29/2025 and 2,200 shares on 09/15/2025, each with disclosed gross proceeds.

Mohawk Industries (MHK) reported Q3 2025 results. Net sales were $2,757.9 million, up slightly from $2,719.0 million a year ago, while gross profit fell to $654.9 million from $692.6 million. Operating income declined to $136.7 million from $212.3 million. Net earnings were $108.8 million, or $1.75 per diluted share, compared to $162.0 million, or $2.55 per diluted share.

Segment trends were mixed: Global Ceramic sales rose to $1,104.7 million (from $1,058.0 million), Flooring ROW increased to $716.4 million (from $687.0 million), and Flooring NA declined to $936.8 million (from $974.0 million). The quarter included restructuring costs of $46.7 million, with $44.1 million recorded in cost of sales. Year to date, restructuring costs totaled $101.4 million. Operating cash flow reached $596.6 million for the nine months, with capital expenditures of $245.6 million and share repurchases of $108.7 million. Cash was $516.2 million and long-term debt was $1,743.3 million at quarter end. Shares outstanding were 61,821,362 as of October 22, 2025.

Mohawk Industries furnished an 8-K under Item 2.02 to announce it issued a press release reporting earnings for the fiscal quarter ended September 27, 2025. The press release, dated October 23, 2025, is attached as Exhibit 99.1.

The Company states the Item 2.02 information, including Exhibit 99.1, is being furnished and shall not be deemed filed or incorporated by reference except as expressly set forth by specific reference.

Mohawk Industries insider transaction summary: Suzanne Helen (reporting name shown as Helen Suzanne L) reported two sales of Mohawk Industries common stock on 09/12/2025. The filings show sales of 909 shares at a weighted average price of $137.50 (range $137.43–$137.65) and 1,291 shares at a weighted average price of $136.98 (range $136.90–$137.06). Following the reported transactions the filing lists beneficial ownership positions of 86,784 shares and 85,493 shares (both held indirectly through a PASTrust for Suzanne Helen), and an additional 141,646 shares held indirectly by a Family Limited Partnership in which the reporting person shares equal control with two other family members. The filer disclaims beneficial ownership of partnership shares beyond her pecuniary interest.

Mohawk Industries (MHK) notice reports a proposed sale under Rule 144 of 2,200 common shares through TD Securities on 09/12/2025 with an aggregate market value of $301,838.16. The filing identifies total outstanding shares of 62,520,000. The shares being sold were originally acquired on 02/29/2012 by company disbursement from Mohawk, with an indicated amount of 395,202 shares acquired at that time. The filing also lists multiple sales by the Lorberbaum family for Suzanne L. Helen totaling recent dispositions in July–September 2025.

Suzanne Helen, identified as an officer of Mohawk Industries, Inc. (MHK), reported two market sales of common stock executed pursuant to market orders. On 09/09/2025 she sold 370 shares at a weighted-average price of $135.30. On 09/11/2025 she sold 721 shares at a weighted-average price of $138.87. After those transactions the Form 4 shows 87,693 shares beneficially owned through a PASTrust for Suzanne Helen and 141,646 shares held indirectly by a Family Limited Partnership, with the reporting person disclaiming ownership beyond reported amounts.

The filing includes explanations that the prices are weighted averages from multiple sales and notes the reporting person shares equal control of the partnership general partner with two other family members.

Mohawk Industries (MHK) Form 144 filing reports proposed sale of 721 common shares through TD Securities (USA) LLC, with an aggregate market value of $100,849.23 and approximately 62,520,000 shares outstanding. The securities to be sold were acquired on 02/29/2012 as a company disbursement from Mohawk Industries, with an original amount recorded as 395,202 shares.

The filing also discloses recent sales by "Lorberbaum Family PAST for Suzanne L. Helen" totaling 5,170 shares sold between 07/29/2025 and 09/09/2025 for gross proceeds shown per trade. The notice includes the seller's representation that they do not possess undisclosed material adverse information.

Form 144 notice for Mohawk Industries (MHK): The filing reports a proposed sale of 370 common shares through TD Securities (USA) LLC on 09/09/2025 with an aggregate market value of $50,060.96. The filing lists 62,520,000 shares outstanding for the class. The securities to be sold were acquired on 02/29/2012 as a company disbursement from Mohawk Industries, with an "amount of securities acquired" shown as 395,202. The notice also discloses three prior sales over the past three months by the Lorberbaum Family Trust for Suzanne L. Helen: 2,500 shares on 07/29/2025 for $301,453.16, 1,500 shares on 08/20/2025 for $192,653.00, and 800 shares on 08/25/2025 for $106,334.88. The filer attests there is no undisclosed material adverse information.